Subscribe to Newsletter
Business & Regulation Business Practice, Trends & Forecasts

Power to the People

Why list the Top 100? First and foremost, we want to celebrate your achievements, your passion and your pride in your work. You are a fascinating, diverse, brilliant and self-effacing community – your work brings therapies to patients around the world, and we want to put you center stage.

We have seen tremendous progress in recent years. In just this single issue of the magazine, you can see advances in every aspect of drug development and manufacture - from formulation strategies to bring even the most intractable molecules to market, to the development of cell factories for cleaner, greener manufacturing, to ever-increasing safety and efficiency standards. We want to recognize the people who have made all this possible, and who continue to push the field forward every day.

To help us compile this list of the great and good, we want to know who has influenced you. Perhaps it is their groundbreaking research, or their generosity in sharing their knowledge with colleagues. It might be their leadership and business acumen, their commitment to raising standards, or their ability to unite the field behind a common cause. Who are the thought leaders, the opinion shapers and the unsung heroes of the industry?

Of course, we expect to see plenty of senior executives on the list, but we want to throw open the door to academics, regulators, consultants and philanthropists too. We welcome nominations from small molecule and biologic sectors, originator and generic, pharma, biotech and contract organizations, from all four corners of the globe and from any discipline. Have your say on who appears on what we anticipate will be a hotly debated and contested list!

You can nominate as many people as you like – nominate yourself, a colleague or a hero of your field. Fill in the short nomination form or drop me a line at [email protected]. Nominations will be reviewed by a panel of judges, who will be responsible for choosing the final 100.

Help us celebrate the people who are pushing the field forward in The Medicine Maker Power List 2015.

charlotte barker signature

Charlotte Barker

Receive content, products, events as well as relevant industry updates from The Medicine Maker and its sponsors.
Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

About the Author
Charlotte Barker

As an Editor at Texere, I’m working closely with our audience to create vibrant, engaging content that reflects the hard work and passion that goes into bringing new medicines to market. I got my start in biomedical publishing as a commissioning editor for healthcare journals and have spent my career covering everything from early-stage research to clinical medicine, so I know my way around. And I can’t think of a more interesting, challenging or important area to be working in.

Related White Papers
Nitrosamines Risk Mitigation: The critical role of excipients and supplier qualification

| Contributed by DFE Pharma GmbH & Co. KG

Performance validation of ScatterX78 against NIST reference materials

| Contributed by Malvern Panalytical

Early stage product development using laser diffraction analysis

| Contributed by Malvern Panalytical

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine